AngioDynamics ANGO FX Effect on Cash
FX Effect on Cash at other companies
Other financials
Where this comes from
Reported directly by AngioDynamics in its filing.
Tagged under the XBRL concept us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents.
The official record: AngioDynamics’s 10-Q, filed April 2, 2026, on SEC EDGAR. View the filing →
Ask your AI about AngioDynamics's fx effect on cash.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is AngioDynamics's FX effect on cash?
- AngioDynamics (ANGO) reported FX effect on cash of $168K in Q4 2025.
- How has AngioDynamics's FX effect on cash changed year-over-year?
- AngioDynamics's FX effect on cash increased by 231.3% year-over-year, from -$128K to $168K.
- What is the long-term trend for AngioDynamics's FX effect on cash?
- Over 2 years (2021 to 2025), AngioDynamics's FX effect on cash has grown at a 6.2% compound annual growth rate (CAGR), from $353K to $398K.
- What does FX effect on cash mean?
- The impact of exchange rate changes on the value of cash and equivalents held in foreign currencies.